Generic placeholder image

Current Diabetes Reviews


ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

The Association of Transcription Factor 7 like 2 Gene Polymorphism with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Author(s): Marianne Fathy Morgan, Randa Fayez Salam, Normeen Hany Rady, Alshaimaa Rezk L.R. Alnaggar*, Soha Hamed Ammar and Nashwa Said Ghanem

Volume 16, Issue 4, 2020

Page: [370 - 375] Pages: 6

DOI: 10.2174/1573399815666190709182713

Price: $65


Background: The exact relationship between the different TCF7L2 gene polymorphisms and the development of diabetic nephropathy (DN) remains unclear.

Objective: To investigate the association of TCF7L2 rs12255372 (G/T) gene polymorphism and diabetic nephropathy (DN) in patients with type 2 diabetes (T2D).

Methods: 100 patients with T2D (50 patients without DN and 50 patients with DN) and 50 age and sex-matched healthy controls (HC) were enrolled in the study. Genotyping for the rs12255372 (G>T) polymorphism in the TCF7L2 gene was performed by real-time PCR.

Results: The rs12255372 polymorphism showed a statistically significant difference between HC and patients with and without DN in both the genotype and allele frequency. However, the rs12255372 polymorphism genotype or allele frequency was not statistically different between patients with DN and those patients without DN. The G allele was found to be higher in patients and the T allele was higher in HC suggesting that the G allele was the risk allele for developing T2D & DN and that the T allele was protective.

Conclusion: rs12255372 TCF7L2 gene polymorphism was strongly associated with type 2 diabetes mellitus and DN. The association between rs12255372 polymorphism and DN was a mere reflection of a complicated diabetes mellitus rather than a direct independent association.

Keywords: Type-2 diabetes mellitus, diabetic nephropathy, TCF7L2 gene, single nucleotide polymorphism, rs12255372, genetic marker.

Global Report on Diabetes. WHO Library Cataloguing-in-Publication Data 2016; 978: 88.
Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases 2014; 2(10): 488-96.
[] [PMID: 25325058]
Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med 2015; 373(6): 548-59.
[] [PMID: 26244308]
Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients 2015; 7(9): 8199-226.
[] [PMID: 26404370]
Kurstjens S, de Baaij JHF, Bouras H, Bindels RJM, Tack CJJ, Hoenderop JGJ. Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. Eur J Endocrinol 2017; 176(1): 11-9.
[] [PMID: 27707767]
Costello RB, Nielsen F. Interpreting magnesium status to enhance clinical care: key indicators. Curr Opin Clin Nutr Metab Care 2017; 20(6): 504-11.
[] [PMID: 28806179]
Ramadass S, Basu S, Srinivasan AR. SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes Metab Syndr 2015; 9(1): 42-5.
[] [PMID: 25470649]
Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5(Suppl. 1): i3-i14.
[] [PMID: 26069819]
Kieboom BCT, Ligthart S, Dehghan A, et al. Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetologia 2017; 60(5): 843-53.
[] [PMID: 28224192]
Gommers LMM, Hoenderop JGJ, Bindels RJM, de Baaij JHF. Hypomagnesemia in type 2 diabetes: A vicious circle? Diabetes 2016; 65(1): 3-13.
[] [PMID: 26696633]
Toprak O, Kurt H, Sarı Y, Şarkış C, Us H, Kırık A. Magnesium replacement improves the metabolic profile in obese and pre-diabetic patients with mild-to-moderate chronic kidney disease: A 3-month, randomised, double-blind, placebo-controlled study. Kidney Blood Press Res 2017; 42(1): 33-42.
[] [PMID: 28297698]
Fang X, Han H, Li M, et al. Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus: A systematic review and meta-regression analysis of prospective cohort studies. Nutrients 2016; 8(11): 739.
[] [PMID: 27869762]
Hruby A, Meigs JB, O’Donnell CJ, Jacques PF, McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care 2014; 37(2): 419-27.
[] [PMID: 24089547]
Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008; 19(1): 50-6.
[] [PMID: 18196987]
Abdulaziz LS. Hypomagnesemia in Iraqi Diabetic Patients and Healthy Controls: An Exploratory study. Al - Kindy College of Medicine Journal 2010; 6(1): 74-80.
Seyoum B, Siraj ES, Saenz C, Abdulkadir J. Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis 2008; 18(2): 147-51.
[PMID: 18507265]
Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypo- and hypermagnesemia in an Iranian urban population. Ann Hum Biol 2011; 38(2): 150-5.
[] [PMID: 20626252]
Hyassat D, Al Sitri E, Batieha A, El-Khateeb M, Ajlouni K. Prevalence of hypomagnesaemia among obese type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG). Int J Endocrinol Metab 2014; 12(3)e17796
[] [PMID: 25237327]
Jamali AA, Jamali GM, Jamali AA, et al. Association of low serum magnesium levels in type 2 diabetes mellitus with &without hypertension. Open J Prev Med 2018; 8(3): 57-69.

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy